tiprankstipranks
Advertisement
Advertisement
Orthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
PremiumCompany AnnouncementsOrthocell Flags Risks and Confidentiality in Q3 FY26 Investor Briefing
2M ago
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
Premium
Company Announcements
Orthocell records first U.S. military hospital case for Remplir after DoD–VA approval
2M ago
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
Premium
Company Announcements
Orthocell Wins U.S. Defence and VA Access for Remplir Nerve Repair Device
3M ago
Orthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
PremiumCompany AnnouncementsOrthocell Issues New Retention and Performance Rights Under Employee Incentive Plan
4M ago
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
Premium
Company Announcements
Orthocell Taps LEDA for UK Launch of Remplir Nerve Repair Device
4M ago
Orthocell director Michael McNulty increases on‑market shareholding
Premium
Company Announcements
Orthocell director Michael McNulty increases on‑market shareholding
4M ago
Orthocell Posts Record Revenue as Remplir Global Rollout Accelerates
PremiumCompany AnnouncementsOrthocell Posts Record Revenue as Remplir Global Rollout Accelerates
5M ago
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
Premium
Company Announcements
Orthocell Deepens Stake in Marine Biomedical and Secures Rights to PearlBone Bone Regeneration Technology
6M ago
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
Premium
Company Announcements
Orthocell Delivers Seventh Straight Record Quarter as Remplir Expansion Gains Pace in North America
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100